FGF14-AS2, as an antisense lncRNA transcribed from the opposite strand of FGF14, can significantly inhibit the osteolytic metastasis of breast cancer by down-regulating the RUNX2/RANKL axis. This evidence concerns the gene FGF14 and breast carcinoma.